On the public citation graph
Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy
0 signed · 179 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/adma.201104763openalex-snapshot
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
inferredcites →https://doi.org/10.1002/art.39485openalex-snapshot
In Vivo Therapeutic Success of MicroRNA‐155 Antagomir in a Mouse Model of Lupus Alveolar Hemorrhage
inferredcites →https://doi.org/10.1002/mc.22710openalex-snapshot
Upregulation of microRNA‐135b and microRNA‐182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway
inferredcites →https://doi.org/10.1002/open.201600072openalex-snapshot
Hyperbranched Polyglycerol‐Induced Porous Silica Nanoparticles as Drug Carriers for Cancer Therapy In Vitro and In Vivo
inferredcites →https://doi.org/10.1007/s10555-017-9724-7openalex-snapshot
miR-155 in cancer drug resistance and as target for miRNA-based therapeutics
inferredcites →https://doi.org/10.1007/s10637-016-0407-yopenalex-snapshot
Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
inferredcites →https://doi.org/10.1007/s12033-010-9321-2openalex-snapshot
Multiple Drug Resistance Mechanisms in Cancer
inferredcites →https://doi.org/10.1016/j.addr.2014.09.004openalex-snapshot
Therapeutic microRNAs targeting the NF-kappa B signaling circuits of cancers
inferredcites →https://doi.org/10.1016/j.bbrc.2012.09.126openalex-snapshot
Adrenaline promotes cell proliferation and increases chemoresistance in colon cancer HT29 cells through induction of miR-155
inferredcites →https://doi.org/10.1016/j.biomaterials.2014.01.019openalex-snapshot
Nucleolin-targeting liposomes guided by aptamer AS1411 for the delivery of siRNA for the treatment of malignant melanomas
inferredcites →https://doi.org/10.1016/j.canlet.2017.04.007openalex-snapshot
microRNAs as cancer therapeutics: A step closer to clinical application
inferredcites →https://doi.org/10.1016/j.ijpharm.2016.11.027openalex-snapshot
Polyethylenimine-functionalized carbon nanotubes tagged with AS1411 aptamer for combination gene and drug delivery into human gastric cancer cells
inferredcites →https://doi.org/10.1016/j.jconrel.2013.03.020openalex-snapshot
Lactosylated gramicidin-based lipid nanoparticles (Lac-GLN) for targeted delivery of anti-miR-155 to hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/j.jconrel.2014.06.037openalex-snapshot
Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo
inferredcites →https://doi.org/10.1016/j.nano.2014.08.013openalex-snapshot
Targeted delivery of anticancer drugs by aptamer AS1411 mediated Pluronic F127/cyclodextrin-linked polymer composite micelles
inferredcites →https://doi.org/10.1016/s0140-6736(16)31715-9openalex-snapshot
Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial
inferredcites →https://doi.org/10.1016/s0959-8049(16)61409-0openalex-snapshot
Targeting miR-155 to resensitize lung cancer to chemotherapy
inferredcites →https://doi.org/10.1021/acsami.5b04359openalex-snapshot
Facile Synthesis of Gold Nanospheres Modified by Positively Charged Mesoporous Silica, Loaded with Near-Infrared Fluorescent Dye, for in Vivo X-ray Computed Tomography and Fluorescence Dual Mode Imaging
inferredcites →https://doi.org/10.1021/acsami.5b09195openalex-snapshot
Redox-Responsive Polyphosphoester-Based Micellar Nanomedicines for Overriding Chemoresistance in Breast Cancer Cells
inferredcites →https://doi.org/10.1021/acsami.7b06353openalex-snapshot
pH-Responsive Dimeric Zinc(II) Phthalocyanine in Mesoporous Silica Nanoparticles as an Activatable Nanophotosensitizing System for Photodynamic Therapy
inferredcites →https://doi.org/10.1021/nn405809copenalex-snapshot
Polydopamine-Based Simple and Versatile Surface Modification of Polymeric Nano Drug Carriers
inferredcites →https://doi.org/10.1038/cmi.2009.43openalex-snapshot
NF-κB Signaling Pathway, Inflammation and Colorectal Cancer
inferredcites →https://doi.org/10.1038/emboj.2012.45openalex-snapshot
A novel miR‐155/miR‐143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells
inferredcites →https://doi.org/10.1038/leu.2014.231openalex-snapshot
NF-κB/STAT5/miR-155 network targets PU.1 in FLT3-ITD-driven acute myeloid leukemia
inferredcites →https://doi.org/10.1038/mtna.2015.23openalex-snapshot
siRNA Versus miRNA as Therapeutics for Gene Silencing
inferredcites →https://doi.org/10.1038/nature13905openalex-snapshot
MicroRNA silencing for cancer therapy targeted to the tumour microenvironment
inferredcites →https://doi.org/10.1038/ni.2060openalex-snapshot
Inflammation meets cancer, with NF-κB as the matchmaker
inferredcites →https://doi.org/10.1038/nrc2789openalex-snapshot
ABC transporters in cancer: more than just drug efflux pumps
inferredcites →https://doi.org/10.1038/nrg1379openalex-snapshot
MicroRNAs: small RNAs with a big role in gene regulation
inferredcites →https://doi.org/10.1039/c2jm34825jopenalex-snapshot
Antimicrobial effect of polydopamine coating on Escherichia coli
inferredcites →https://doi.org/10.1039/c2nr30316gopenalex-snapshot
A self-assembled polydopamine film on the surface of magnetic nanoparticles for specific capture of protein
inferredcites →https://doi.org/10.1039/c6tb01790hopenalex-snapshot
An injectable miRNA-activated matrix for effective bone regeneration in vivo
inferredcites →https://doi.org/10.1039/c6tb03365bopenalex-snapshot
Nucleolin-targeted selenium nanocomposites with enhanced theranostic efficacy to antagonize glioblastoma
inferredcites →https://doi.org/10.1039/c7ra05135bopenalex-snapshot
DOX-loaded pH-sensitive mesoporous silica nanoparticles coated with PDA and PEG induce pro-death autophagy in breast cancer
inferredcites →https://doi.org/10.1039/c7tb00995jopenalex-snapshot
Oxygen-dependent generation of a graded polydopamine coating on nanofibrous materials for controlling stem cell functions
inferredcites →https://doi.org/10.1039/c7tb01385jopenalex-snapshot
Antibody-conjugated mesoporous silica nanoparticles for brain microvessel endothelial cell targeting
inferredcites →https://doi.org/10.1039/c7tb01704aopenalex-snapshot
Mesoporous silica nanoparticles with lactose-mediated targeting effect to deliver platinum( iv ) prodrug for liver cancer therapy
inferredcites →https://doi.org/10.1039/c7tb01833aopenalex-snapshot
Biomaterials for polynucleotide delivery to anchorage-independent cells
inferredcites →https://doi.org/10.1039/c7tb02163aopenalex-snapshot
A highly selective dual-therapeutic nanosystem for simultaneous anticancer and antiangiogenesis therapy
inferredcites →https://doi.org/10.1039/c7tb02218bopenalex-snapshot
Stable, polyvalent aptamer-conjugated near-infrared fluorescent nanocomposite for high-performance cancer cell-targeted imaging and therapy
inferredcites →https://doi.org/10.1039/c7tb02559aopenalex-snapshot
Integration of polymers in the pore space of mesoporous nanocarriers for drug delivery
inferredcites →https://doi.org/10.1053/j.gastro.2011.07.038openalex-snapshot
Neurotensin Signaling Activates MicroRNAs-21 and -155 and Akt, Promotes Tumor Growth in Mice, and Is Increased in Human Colon Tumors
inferredcites →https://doi.org/10.1073/pnas.1201516109openalex-snapshot
Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma
inferredcites →https://doi.org/10.1126/science.1147241openalex-snapshot
Mussel-Inspired Surface Chemistry for Multifunctional Coatings
inferredcites →https://doi.org/10.1158/0008-5472.can-09-4250openalex-snapshot
MicroRNA-155 Functions as an OncomiR in Breast Cancer by Targeting the Suppressor of Cytokine Signaling 1 Gene
inferredcites →https://doi.org/10.1158/1078-0432.ccr-16-1025openalex-snapshot
Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers
inferredcites →https://doi.org/10.1182/blood.v128.22.1829.1829openalex-snapshot
Preliminary Results of a Phase 1 Trial Evaluating MRG-106, a Synthetic microRNA Antagonist (LNA antimiR) of microRNA-155, in Patients with CTCL
inferredcites →https://doi.org/10.1186/1471-2199-14-24openalex-snapshot
Identification of an NF-κB p50/p65-responsive site in the human MIR155HG promoter
inferredcites →https://doi.org/10.1186/2043-9113-3-17openalex-snapshot
The multiple roles of microRNA-155 in oncogenesis
inferredcites →https://doi.org/10.1517/17425247.2013.798640openalex-snapshot
Nanoparticle-mediated delivery of therapeutic genes: focus on miRNA therapeutics
inferredcites →https://doi.org/10.15252/emmm.201100899openalex-snapshot
Development of microRNA therapeutics is coming of age
inferredcites →https://doi.org/10.2147/ijn.s117495openalex-snapshot
Mesoporous silica nanoparticles for stimuli-responsive controlled drug delivery: advances, challenges, and outlook
inferredcites →https://doi.org/10.2217/epi-2016-0035openalex-snapshot
Clinical Development of TargomiRs, a miRNA Mimic-Based Treatment for Patients with Recurrent Thoracic Cancer
inferredcites →https://doi.org/10.3892/ijo.2016.3503openalex-snapshot
Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: New trends in the development of miRNA therapeutic strategies in oncology (Review)
inferredcites →https://doi.org/10.4149/neo_2014_032openalex-snapshot
miR-155 as a diagnostic and prognostic marker in hematological and solid malignancies
inferredcites →https://doi.org/10.7150/thno.14184openalex-snapshot
Polydopamine-Based Surface Modification of Novel Nanoparticle-Aptamer Bioconjugates for In Vivo Breast Cancer Targeting and Enhanced Therapeutic Effects
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4856703openalex-extracted
Towards the Preparation of Smart Drug Delivery Platforms for Colorectal Cancer Therapy: Biocompatible and Targeted Mesoporous Silica Nanoparticles with Deferiprone-Copper Complex Gatekeeper
inferred← citeshttps://doi.org/10.1002/jcb.27918openalex-snapshot
miRNA‐155 and miRNA‐181a as prognostic biomarkers for pediatric acute lymphoblastic leukemia
inferred← citeshttps://doi.org/10.1002/kjm2.12365openalex-snapshot
Co‐delivery of cisplatin and oleanolic acid by silica nanoparticles‐enhanced apoptosis and reverse multidrug resistance in lung cancer
inferred← citeshttps://doi.org/10.1002/mabi.202000222openalex-snapshot
Mussel‐Inspired Polydopamine: The Bridge for Targeting Drug Delivery System and Synergistic Cancer Treatment
inferred← citeshttps://doi.org/10.1002/smll.201902242openalex-snapshot
New Advances in In Vivo Applications of Gated Mesoporous Silica as Drug Delivery Nanocarriers
inferred← citeshttps://doi.org/10.1002/tcr.202000170openalex-snapshot
Polydopamine‐Based Nanoparticles for Photothermal Therapy/Chemotherapy and their Synergistic Therapy with Autophagy Inhibitor to Promote Antitumor Treatment
inferred← citeshttps://doi.org/10.1002/wrna.1637openalex-snapshot
Role of microRNAs in the pathophysiology of addiction
inferred← citeshttps://doi.org/10.1007/978-3-030-58174-9_5openalex-snapshot
Mesoporous Silica Nanoparticles as Carriers for Biomolecules in Cancer Therapy
inferred← citeshttps://doi.org/10.1007/978-3-032-08824-6_22openalex-snapshot
MicroRNAs: Innovative Clinical Tools for Diagnosis, Prognosis, and Therapy in Colorectal Cancer
inferred← citeshttps://doi.org/10.1007/978-981-33-4838-7_6openalex-snapshot
Aptamers for Targeted Therapy
inferred← citeshttps://doi.org/10.1007/978-981-99-2196-6_75-1openalex-snapshot
Applications of Nanotechnology in Converging the Biomarker Science for Advancement in Cancer Detection and Treatment
inferred← citeshttps://doi.org/10.1007/978-981-99-2196-6_75-2openalex-snapshot
Applications of Nanotechnology in Converging the Biomarker Science for Advancement in Cancer Detection and Treatment
inferred← citeshttps://doi.org/10.1007/978-981-99-6263-1_75openalex-snapshot
Applications of Nanotechnology in Converging the Biomarker Science for Advancement in Cancer Detection and Treatment
inferred← citeshttps://doi.org/10.1007/s00018-019-03317-9openalex-snapshot
Nanoscale delivery systems for microRNAs in cancer therapy
inferred← citeshttps://doi.org/10.1007/s00109-025-02574-5openalex-snapshot
CD8 + T Cells in Gastrointestinal Cancer: a Perspective on Targeting MicroRNA
inferred← citeshttps://doi.org/10.1007/s00384-024-04617-8openalex-snapshot
Analysis of the differential expression of serum miR-21-5p, miR-135-5p, and miR-155-5p by Bifidobacterium triplex viable capsules during the perioperative stage of colorectal cancer
inferred← citeshttps://doi.org/10.1007/s10565-024-09920-2openalex-snapshot
MicroRNA-155 and its exosomal form: Small pieces in the gastrointestinal cancers puzzle
inferred← citeshttps://doi.org/10.1007/s11033-023-08810-wopenalex-snapshot
MicroRNAs and colorectal cancer: clinical potential and regulatory networks
inferred← citeshttps://doi.org/10.1007/s11095-022-03383-yopenalex-snapshot
Simultaneous Targeting of Multiple oncomiRs with Phosphorothioate or PNA-Based Anti-miRs in Lymphoma Cell Lines
inferred← citeshttps://doi.org/10.1007/s12032-025-02678-5openalex-snapshot
A review on the advancement of polydopamine (PDA)-based nanomaterials for cancer treatment
inferred← citeshttps://doi.org/10.1007/s13577-023-00899-2openalex-snapshot
Dysregulated microRNAs participate in the crosstalk between colorectal cancer and atrial fibrillation
inferred← citeshttps://doi.org/10.1007/s40005-023-00632-zopenalex-snapshot
Recent progress and drug delivery applications of surface-functionalized inorganic nanoparticles in cancer therapy
inferred← citeshttps://doi.org/10.1016/b978-0-323-85881-6.00009-9openalex-snapshot
Aptamer-functionalized silicon nanoparticles for targeted cancer therapy
inferred← citeshttps://doi.org/10.1016/b978-0-323-89774-7.00017-0openalex-snapshot
MicroRNA interference
inferred← citeshttps://doi.org/10.1016/b978-0-443-18929-6.00008-6openalex-snapshot
Multilayered and nanoencapsulated polymer films for drug delivery
inferred← citeshttps://doi.org/10.1016/b978-0-443-24806-1.00016-9openalex-snapshot
Emerging trends of mesoporous silica nanoparticles in colon targeting
inferred← citeshttps://doi.org/10.1016/b978-0-443-33984-4.00021-3openalex-snapshot
Smart nanoencapsulation for cancer therapy
inferred← citeshttps://doi.org/10.1016/bs.ircmb.2025.01.008openalex-snapshot
Epigenetic insights of microRNAs: Pioneering cancer detection via advanced biosensors
inferred← citeshttps://doi.org/10.1016/j.adcanc.2024.100114openalex-snapshot
Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success
inferred← citeshttps://doi.org/10.1016/j.biochi.2018.09.009openalex-snapshot
Nucleic acid aptamers in diagnosis of colorectal cancer
inferred← citeshttps://doi.org/10.1016/j.biopha.2022.113932openalex-snapshot
Engineered nanoparticles as emerging gene/drug delivery systems targeting the nuclear factor-κB protein and related signaling pathways in cancer
inferred← citeshttps://doi.org/10.1016/j.biopha.2022.114031openalex-snapshot
The diagnostic, prognostic role and molecular mechanism of miR-328 in human cancer
inferred← citeshttps://doi.org/10.1016/j.biopha.2023.114661openalex-snapshot
The role of KLF transcription factor in the regulation of cancer progression
inferred← citeshttps://doi.org/10.1016/j.bios.2025.117910openalex-snapshot
Ultra-sensitive solid-state nanochannel electrochemical biosensor based on interfacial charge density modulation and signal synergistic amplification for microRNA-155 detection
inferred← citeshttps://doi.org/10.1016/j.canlet.2021.03.025openalex-snapshot
Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
inferred← citeshttps://doi.org/10.1016/j.cca.2025.120681openalex-snapshot
Multiple roles of microRNA-155 in chronic kidney diseases
inferred← citeshttps://doi.org/10.1016/j.cclet.2026.113069openalex-snapshot
Epigenetically tunable biomaterials for immune modulation
inferred← citeshttps://doi.org/10.1016/j.ccr.2021.213949openalex-snapshot
Application of smart nanoparticles as a potential platform for effective colorectal cancer therapy
inferred← citeshttps://doi.org/10.1016/j.ccr.2022.214540openalex-snapshot
Nanoarchitectured manganese dioxide (MnO2)-based assemblies for biomedicine
inferred← citeshttps://doi.org/10.1016/j.cellsig.2020.109910openalex-snapshot
MicroRNAs as potential investigative and predictive biomarkers in colorectal cancer
inferred← citeshttps://doi.org/10.1016/j.colsurfb.2020.110985openalex-snapshot
Fabrication of aptamer modified TiO2 nanofibers for specific capture of circulating tumor cells
inferred← citeshttps://doi.org/10.1016/j.drudis.2019.11.006openalex-snapshot
Improving the therapeutic efficiency of noncoding RNAs in cancers using targeted drug delivery systems
inferred← citeshttps://doi.org/10.1016/j.ejps.2019.105110openalex-snapshot
Analgesic and antipruritic effects of oxymatrine sustained-release microgel cream in a mouse model of inflammatory itch and pain
inferred← citeshttps://doi.org/10.1016/j.fitote.2026.107451openalex-snapshot
MicroRNA modulation and crosstalk of SREBP and NF-κB pathways in herbal nanoparticle therapies for hypercholesterolemia
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2019.11.118openalex-snapshot
Therapeutic applications of AS1411 aptamer, an update review
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2023.127060openalex-snapshot
Engineered mesoporous silica nanoparticles, new insight nanoplatforms into effective cancer gene therapy
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2025.140134openalex-snapshot
MiRNA-155: A double-edged sword in colorectal cancer progression and drug resistance mechanisms
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2025.143536openalex-snapshot
RTA activates the activity of the miR-155 promoter region and promotes the growth and invasion of endothelial cells through the regulatory network of miR-155/GATA3/STAT3
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2025.145463openalex-snapshot
Nanocarriers for microRNA delivery: A review of applied platforms and perspectives
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2019.118483openalex-snapshot
Aptamers as the chaperones (Aptachaperones) of drugs-from siRNAs to DNA nanorobots
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2023.122792openalex-snapshot
Multilayered polymer coating modulates mucoadhesive and biological properties of camptothecin-loaded lipid nanocapsules
inferred← citeshttps://doi.org/10.1016/j.jcis.2018.05.033openalex-snapshot
Macroporous silica nanoparticles for delivering Bcl2-function converting peptide to treat multidrug resistant-cancer cells
inferred← citeshttps://doi.org/10.1016/j.jconrel.2021.07.029openalex-snapshot
Advanced mesoporous silica nanocarriers in cancer theranostics and gene editing applications
inferred← citeshttps://doi.org/10.1016/j.jddst.2023.104487openalex-snapshot
Strategies of nanomedicine for targeting the signaling pathways of Colorectal cancer
inferred← citeshttps://doi.org/10.1016/j.jddst.2024.106087openalex-snapshot
Towards the preparation of smart drug delivery platforms for colorectal cancer therapy: Biocompatible and targeted mesoporous silica nanoparticles with the deferiprone-copper complex gatekeeper
inferred← citeshttps://doi.org/10.1016/j.jddst.2025.107798openalex-snapshot
Molecular and cellular remodeling of the colorectal tumor microenvironment using nanoparticles
inferred← citeshttps://doi.org/10.1016/j.mam.2019.09.004openalex-snapshot
The extensive role of miR-155 in malignant and non-malignant diseases
inferred← citeshttps://doi.org/10.1016/j.mam.2021.101003openalex-snapshot
From bench side to clinic: Potential and challenges of RNA vaccines and therapeutics in infectious diseases
inferred← citeshttps://doi.org/10.1016/j.microc.2021.106640openalex-snapshot
Recent progress in the development of aptasensors for cancer diagnosis: Focusing on aptamers against cancer biomarkers
inferred← citeshttps://doi.org/10.1016/j.molstruc.2022.132922openalex-snapshot
Recent trends in mesoporous silica nanoparticles of rode-like morphology for cancer theranostics: A review
inferred← citeshttps://doi.org/10.1016/j.nano.2020.102303openalex-snapshot
Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: Current status and future perspectives
inferred← citeshttps://doi.org/10.1016/j.nantod.2020.100914openalex-snapshot
Stimulus-responsive sequential release systems for drug and gene delivery
inferred← citeshttps://doi.org/10.1016/j.prp.2023.154962openalex-snapshot
From inflammation to metastasis: The central role of miR-155 in modulating NF-κB in cancer
inferred← citeshttps://doi.org/10.1016/j.semcancer.2019.06.017openalex-snapshot
Engineered nanoparticles for imaging and drug delivery in colorectal cancer
inferred← citeshttps://doi.org/10.1016/j.trac.2019.115759openalex-snapshot
Aptamer-conjugated mesoporous silica nanoparticles for simultaneous imaging and therapy of cancer
inferred← citeshttps://doi.org/10.1016/j.trac.2019.115778openalex-snapshot
Multifunctional aptasensors based on mesoporous silica nanoparticles as an efficient platform for bioanalytical applications: Recent advances
inferred← citeshttps://doi.org/10.1021/acsami.3c10065openalex-snapshot
Material and Design Toolkit for Drug Delivery: State of the Art, Trends, and Challenges
inferred← citeshttps://doi.org/10.1021/acsomega.0c02072openalex-snapshot
Nanostructured Lipid Carriers Delivering Sorafenib to Enhance Immunotherapy Induced by Doxorubicin for Effective Esophagus Cancer Therapy
inferred← citeshttps://doi.org/10.1039/d0bm01502dopenalex-snapshot
Gas-generating mesoporous silica nanoparticles with rapid localized drug release for enhanced chemophotothermal tumor therapy
inferred← citeshttps://doi.org/10.1039/d2na00446aopenalex-snapshot
Construction of a redox-responsive drug delivery system utilizing the volume of AS1411 spatial configuration gating mesoporous silica pores
inferred← citeshttps://doi.org/10.1089/dna.2021.0100openalex-snapshot
Molecular Mechanisms of miR-1271 Dysregulation in Human Cancer
inferred← citeshttps://doi.org/10.1111/cpr.13130openalex-snapshot
Aptamer‐conjugated mesoporous polydopamine for docetaxel targeted delivery and synergistic photothermal therapy of prostate cancer
inferred← citeshttps://doi.org/10.1155/2019/2740923openalex-snapshot
Nanovectors Design for Theranostic Applications in Colorectal Cancer
inferred← citeshttps://doi.org/10.1155/2022/7437281openalex-snapshot
miR-155: An Important Role in Inflammation Response
inferred← citeshttps://doi.org/10.1186/s12951-021-01131-9openalex-snapshot
Recent developments in mesoporous polydopamine-derived nanoplatforms for cancer theranostics
inferred← citeshttps://doi.org/10.1186/s12964-025-02554-9openalex-snapshot
Harnessing nanomedicine to target NF-κB signalling in cancer: at the intersection of inflammatory signalling, metabolic reprogramming, and therapeutic innovation
inferred← citeshttps://doi.org/10.1186/s41544-019-0024-yopenalex-snapshot
Recent progress in microRNA-based delivery systems for the treatment of human disease
inferred← citeshttps://doi.org/10.1186/s41544-019-0026-9openalex-snapshot
microRNAs as therapeutic targets in intestinal diseases
inferred← citeshttps://doi.org/10.14670/hh-18-171openalex-snapshot
Roles of microRNAs as non-invasive biomarker and therapeutic target in colorectal cancer.
inferred← citeshttps://doi.org/10.14715/cmb/2023.69.7.2openalex-snapshot
The linkage between microRNA and cancer and its delivery as cancer therapy: A mini-review
inferred← citeshttps://doi.org/10.1515/tjb-2023-0086openalex-snapshot
Exploring nanotechnology-based approaches using miRNAs to treat neurodegenerative disorders
inferred← citeshttps://doi.org/10.2147/ijn.s270939openalex-snapshot
Delivery of Rapamycin by Liposomes Synergistically Enhances the Chemotherapy Effect of 5-Fluorouracil on Colorectal Cancer
inferred← citeshttps://doi.org/10.2147/ott.s180971openalex-snapshot
MicroRNA-18a promotes hepatocellular carcinoma proliferation, migration, and invasion by targeting Bcl2L10
inferred← citeshttps://doi.org/10.2147/ott.s256148openalex-snapshot
LINC01089 Blocks the Proliferation and Metastasis of Colorectal Cancer Cells via Regulating miR-27b-3p/HOXA10 Axis
inferred← citeshttps://doi.org/10.2174/1381612827666211109113305openalex-snapshot
Role of miRNAs in Cancer Diagnostics and Therapy: A Recent Update
inferred← citeshttps://doi.org/10.2174/1389201021666200420101613openalex-snapshot
MicroRNA: Promising Roles in Cancer Therapy
inferred← citeshttps://doi.org/10.21873/cgp.20336openalex-snapshot
Machine-learning-based Analysis Identifies miRNA Expression Profile for Diagnosis and Prediction of Colorectal Cancer: A Preliminary Study
inferred← citeshttps://doi.org/10.2217/nnm-2021-0381openalex-snapshot
Nanoparticulate Strategies for The Delivery of miRNA Mimics and Inhibitors in Anticancer Therapy and its Potential Utility in Oral Submucous Fibrosis
inferred← citeshttps://doi.org/10.22270/jddt.v15i8.7336openalex-snapshot
Biogenesis and implication of miRNAs in the development of diseases and their theranostic inhibitions
inferred← citeshttps://doi.org/10.3389/fbioe.2022.1095837openalex-snapshot
Using magnetic mesoporous silica nanoparticles armed with EpCAM aptamer as an efficient platform for specific delivery of 5-fluorouracil to colorectal cancer cells
inferred← citeshttps://doi.org/10.3389/fgene.2020.577948openalex-snapshot
Downregulation of miR-654-3p in Colorectal Cancer Indicates Poor Prognosis and Promotes Cell Proliferation and Invasion by Targeting SRC
inferred← citeshttps://doi.org/10.3389/fimmu.2025.1579661openalex-snapshot
CTHRC1: a key player in colorectal cancer progression and immune evasion
inferred← citeshttps://doi.org/10.3389/fonc.2024.1460201openalex-snapshot
Global research progress of nanomedicine and colorectal cancer: a bibliometrics and visualization analysis
inferred← citeshttps://doi.org/10.3389/fphar.2022.981799openalex-snapshot
Research progress on microRNA in gout
inferred← citeshttps://doi.org/10.3390/cancers12040895openalex-snapshot
Differentially Methylated Ultra-Conserved Regions Uc160 and Uc283 in Adenomas and Adenocarcinomas Are Associated with Overall Survival of Colorectal Cancer Patients
inferred← citeshttps://doi.org/10.3390/cancers12061532openalex-snapshot
A Driver Never Works Alone—Interplay Networks of Mutant p53, MYC, RAS, and Other Universal Oncogenic Drivers in Human Cancer
inferred← citeshttps://doi.org/10.3390/cancers12092410openalex-snapshot
A Distinctive microRNA (miRNA) Signature in the Blood of Colorectal Cancer (CRC) Patients at Surgery
inferred← citeshttps://doi.org/10.3390/cancers13092058openalex-snapshot
Nanomedicine to Overcome Multidrug Resistance Mechanisms in Colon and Pancreatic Cancer: Recent Progress
inferred← citeshttps://doi.org/10.3390/cancers14112677openalex-snapshot
Nanomedicine for the Delivery of RNA in Cancer
inferred← citeshttps://doi.org/10.3390/cancers14153818openalex-snapshot
miRacle of microRNA-Driven Cancer Nanotherapeutics
inferred← citeshttps://doi.org/10.3390/cancers17132135openalex-snapshot
Diagnostic and Therapeutic Potential of Selected microRNAs in Colorectal Cancer: A Literature Review
inferred← citeshttps://doi.org/10.3390/cells10113097openalex-snapshot
The Challenges and Opportunities in the Development of MicroRNA Therapeutics: A Multidisciplinary Viewpoint
inferred← citeshttps://doi.org/10.3390/cells14231905openalex-snapshot
The Growing Significance of microRNAs in Osteoporosis
inferred← citeshttps://doi.org/10.3390/cells9010029openalex-snapshot
MicroRNA-Based Combinatorial Cancer Therapy: Effects of MicroRNAs on the Efficacy of Anti-Cancer Therapies
inferred← citeshttps://doi.org/10.3390/ijms19092791openalex-snapshot
The Dual Role of MicroRNAs in Colorectal Cancer Progression
inferred← citeshttps://doi.org/10.3390/ijms21093253openalex-snapshot
MicroRNA Nanotherapeutics for Lung Targeting. Insights into Pulmonary Hypertension
inferred← citeshttps://doi.org/10.3390/ijms24076349openalex-snapshot
Mesoporous Silica Nanoparticles as a Potential Nanoplatform: Therapeutic Applications and Considerations
inferred← citeshttps://doi.org/10.3390/ijms26167883openalex-snapshot
The Pivotal Role of NF-κB in Glioblastoma: Mechanisms of Activation and Therapeutic Implications
inferred← citeshttps://doi.org/10.3390/life12111937openalex-snapshot
Aptamer-Based Probes for Cancer Diagnostics and Treatment
inferred← citeshttps://doi.org/10.3390/molecules29194737openalex-snapshot
Recent Advances and Prospects of Nucleic Acid Therapeutics for Anti-Cancer Therapy
inferred← citeshttps://doi.org/10.3390/mps4010010openalex-snapshot
Recent Advances in miRNA Delivery Systems
inferred← citeshttps://doi.org/10.3390/nano11123330openalex-snapshot
Novel Perspectives towards RNA-Based Nano-Theranostic Approaches for Cancer Management
inferred← citeshttps://doi.org/10.3390/pharmaceutics12050432openalex-snapshot
Mesoporous Silica Nanoparticles as Carriers for Therapeutic Biomolecules
inferred← citeshttps://doi.org/10.3390/pharmaceutics12060526openalex-snapshot
Mesoporous Silica Nanoparticles for Co-Delivery of Drugs and Nucleic Acids in Oncology: A Review
inferred← citeshttps://doi.org/10.3390/pharmaceutics12070649openalex-snapshot
Silica-Based Gene Delivery Systems: From Design to Therapeutic Applications
inferred← citeshttps://doi.org/10.3390/pharmaceutics13081321openalex-snapshot
Nanocarriers as a Tool for the Treatment of Colorectal Cancer
inferred← citeshttps://doi.org/10.3390/pharmaceutics14081620openalex-snapshot
Encapsulation of miRNA and siRNA into Nanomaterials for Cancer Therapeutics
inferred← citeshttps://doi.org/10.3748/wjg.v25.i14.1697openalex-snapshot
Functional role of long non-coding RNA CASC19/miR-140-5p/CEMIP axis in colorectal cancer progression in vitro
inferred← citeshttps://doi.org/10.3762/bjnano.17.64openalex-snapshot
Nanocarrier strategies to overcome P-glycoprotein-mediated drug resistance in cancer therapy
inferred← citeshttps://doi.org/10.3892/mmr.2018.9518openalex-snapshot
miR‑124 inhibits cell growth through targeting IQGAP1 in colorectal cancer
inferred← citeshttps://doi.org/10.3892/mmr.2019.10325openalex-snapshot
MicroRNA‑214 suppresses the viability, migration and invasion of human colorectal carcinoma cells via targeting transglutaminase 2
inferred← citeshttps://doi.org/10.3892/ol.2020.11457openalex-snapshot
Upregulated miR‑665 expression independently predicts poor prognosis of lung cancer and facilitates tumor cell proliferation, migration and invasion
inferred← citeshttps://doi.org/10.5306/wjco.v15.i6.667openalex-snapshot
Silica nanoparticle design for colorectal cancer treatment: Recent progress and clinical potential
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.